HomeOpen Access NewsOAG 028 - October 2020

OAG 028 - October 2020

How DNA technology helps control the premium quality of Thai Hom Mali Rice

Professor Dr Apichart Vanavichit, at the Rice Science Center, explains how DNA technology can create a high-quality Thai Jasmine Rice.

The three ‘isms’ costing your business money

Here, we learn about the importance of recognising Absenteeism, Presenteeism and Leaveism, so that businesses can proactively address them to reduce costs and support their workers.

District heating: Operation and maintenance

Here, Rie Krabsen and Erik Christiansen of EBO Consult continue to disclose the ins and out of district heating, in particular, discussing operation and maintenance.

COVID-19 and pulmonary fibrosis

Steve Jones, President of EU-IPFF and Chair, Action for Pulmonary Fibrosis in the UK describes the connection between COVID-19 and pulmonary fibrosis.

Nanotechnology: Modern innovation demands regulatory preparedness in risk governance

Monique Groenewold discusses how modern innovation requires regulatory preparedness in risk governance, especially for nanotechnology.

MHL Series B equity financing and global CPG partnerships

Here, we learn how Mile High Labs, a leading processor of hemp-derived cannabinoids, have raised Series B equity financing and are preparing for global CPG partnerships.

Future machines to explore new frontiers in particle physics

Jim Siegrist from the Office of Science at the U.S. Department of Energy, charts how future machines will explore new frontiers in particle physics.

Rethinking Type 1 diabetes with a radically new immunotherapy approach

Jean Van Rampelbergh PhD, VP Clinical & Regulatory at Imcyse SA, introduces Imotopes™, the innovative new immunotherapy approach causing scientists to rethink Type 1 diabetes and its treatment.

Innovative treatments for heart failure

Prof Dr Joost Sluijter, Professor, Cellular and Translational Cardiology at University Medical Center Utrecht shares an in-depth perspective on the needs for innovative treatments for heart failure.

The import of medical cannabis: Germany and the Netherlands

Kathleen Denoodt continues to enlighten us on the subject of medical cannabis, particularly imports to Germany and the Netherlands.

The “Green Deal” Greenhouse: A promise for sustainable food supply

Brite Hellas S.A, discusses the “Green Deal” Greenhouse, A Promise for Sustainable Food Supply starting with problems and needs.

Using eHealth applications to improve care for patients with pulmonary fibrosis

Karen Moor and Marlies Wijsenbeek discuss how pulmonary fibrosis patients can be helped by the new possibilities of eHealth apps.

Vitamin D and immune tolerance in pregnancy and beyond

Drs Yuping Wang and David F. Lewis from Louisiana State University Health Sciences Center – Shreveport discuss the impact of vitamin D in regulating immune tolerance and foetal development in pregnancy.

LRG1: An emerging therapeutic target for the treatment of microvascular dysfunction

John Greenwood PhD and Stephen E. Moss PhD explore the imminent potential of LRG1 as a microvascular dysfunction treatment.

Computer science, software and mathematics: Interactive proof assistants

Dr Nicolas Tabareau from IMT Atlantique Bretagne-Pays de la Loire, provides us with further insight about interactive proof assistants, within the wider field of computer science, software and mathematics.

WFH problems: Innovative solutions maintain business as usual

Sam Newman, Managing Director of OGEL IT LTD explains how innovative solutions help maintain business as usual, even with workers at home.

GERICS coordinates scientific underpinning for a CO2-neutral Germany

Here, GERICS presents how they develop tools and solutions in interdisciplinary collaboration with 9 Helmholtz Centres for a roadmap to make Germany CO2-neutral by 2050.

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders